Pharmaceuticals

Mallinckrodt Acquires Global Specialty Hemostasis Brands From The Medicines Company

Mallinckrodt, a leading specialty biopharmaceutical company, today announced it closed the acquisition of the global portfolio of three commercial-stage topical hemostasis drugs from The Medicines Company.

Read More

FDA Approves New Breast Cancer Treatment for Postmenopausal Women

This week the U.S. Food and Drug Administration (FDA) approved a new drug to treat postmenopausal women with advanced breast cancer who have not already taken other drugs.

Read More

Astellas Pharma Inc. Makes Bid on OSI Pharmaceuticals

The Japanese pharmaceutical company Astellas Pharma Inc. recently made a bid to purchase OSI Pharmaceuticals.

Read More

Cyberonics’ Treatment for Chronic Depression Shows Effective Results

On May 27, Cyberonics Inc. (Nasdaq: CYBX) announced the results of a multicenter, double-blind, FDA study for their VNS Therapy.

Read More

Obesity Not Necessarily Correlated with Wealth

An article recently published in the European Health Journal stated that the poorest in British society were “most likely to be obese.”

Read More

Successful Study on Curavisc

A successful study on Curavisc was recently presented at the 58th annual conference of the North German Association of Orthopedic Surgeons.

Read More

What Color is Your Fat?

In a study published in the New England Journal of Medicine and cited by Time Magazine, researchers found a discrepancy between white fat and brown fat.

Read More

Is Diabetes Getting Younger?

According to a study published in Archives of Pediatrics and Adolescent Medicine, the age of onset of Type II diabetes mellitus is getting younger.

Read More